Biogen Idec News (NASDAQ:BIIB)
| Latest Biogen Idec News Headlines | | Date | Time | Source | | | 06/02/2008 | 9:20AM | PRNUS | BeaconEquity.com Issues TraderNotes on Biotechnology Stocks: TPIM, RXII, VION, CUR, AMGN, GILD, BIIB, GENR
DALLAS, June 2 /PRNewswire/ -- BeaconEquity.com announces the availability of TraderNotes on stocks that are making news today.
Investors can view all of the daily trading notes for free by visiting: http://www.beaconequity.com/m
Today's TraderNotes include: TapImmune Inc. (OTC:TPIM) (BULLETIN BOARD: TPIM) , RXi Pharmaceuticals... More...>> |
| 04/30/2008 | 9:31AM | PRNUS | Seven Summits Research Releases Alerts on C, WMT, CAT, BIIB, and BBT
CHICAGO, April 30 /PRNewswire/ -- Seven Summits Research issues PriceWatch Alerts for key stocks.
Seven Summits Strategic Investments' PriceWatch Alerts are available at
http://www.iotogo.com/s/043008A (Note: You may have to copy this link into your browser then press the [ENTER] key.)
Today's PriceWatch Alerts cover... More...>> |
| 10/15/2007 | 10:54AM | PRNUS | Seven Summits Research Releases Comments on XOM, X, GG, BIIB, and BG
CHICAGO, Oct. 15 /PRNewswire/ -- Seven Summits Research releases NewsBites on key stocks.
Seven Summits Strategic Investments NewsBites are available to all investors at:
http://www.go7now.com/nb/1015Z (Note: You may have to copy this link into your browser then press the [ENTER] key.)
Today's Seven Summits Strategic... More...>> |
| 10/11/2007 | 4:26PM | PRNUS | Phase 2 Data Show Daclizumab Significantly Reduced Multiple Sclerosis Lesions in Patients Receiving Interferon Beta Therapy
- Phase 2 monotherapy trial to be initiated by end of 2007 -
PRAGUE, Czech Republic, Oct. 11 /PRNewswire-FirstCall/ -- Biogen Idec Inc. (NASDAQ:BIIB) and PDL BioPharma, Inc. (PDL) (NASDAQ:PDLI) announced today that Phase 2 data demonstrated a significant reduction in new or enlarged gadolinium-enhancing lesions when... More...>> |
| 09/18/2007 | 6:00AM | PRNUS | LigoCyte Pharmaceuticals Announces Collaboration With Biogen Idec to Develop Anti-CD103 Therapies
BOZEMAN, Mont., Sept. 18 /PRNewswire/ -- LigoCyte Pharmaceuticals, Inc., today announced a strategic partnership with Biogen Idec (NASDAQ:BIIB) to develop therapies targeting CD103 for the treatment of chronic inflammatory diseases including potential respiratory, gastrointestinal, and autoimmune indications. CD103... More...>> |
| 08/24/2007 | 10:53AM | PRNUS | Seven Summits Research Releases Comments on CVX, MRVL, MS, BIIB, and CTX
CHICAGO, Aug. 24 /PRNewswire/ -- Seven Summits Research releases NewsBites on key stocks.
Seven Summits Strategic Investments NewsBites are available to all investors at:
http://www.go7now.com/nb/0824Z (Note: You may have to copy this link into your browser then press the [ENTER] key.)
Today's Seven Summits Strategic... More...>> |
| 08/20/2007 | 12:35PM | PRNUS | Revised version: Veritude Announces Partnership with Biogen Idec for Managed Services Program
-Global Leader in Biotechnology Turns to Veritude to Support Temporary Staffing Requirements-
BOSTON, Aug. 20 /PRNewswire/ -- Veritude, a leading provider of talent acquisition and management services, today announced it has been selected by Biogen Idec (NASDAQ:BIIB), a global leader in the discovery, development, manufacturing... More...>> |
| 07/24/2007 | 9:31AM | PRNUS | Seven Summits Research Releases Alerts on AXP, MCD, NYX, BIIB, and STM
CHICAGO, July 24 /PRNewswire/ -- Seven Summits Research issues PriceWatch Alerts for key stocks.
Seven Summits Strategic Investments' PriceWatch Alerts are available at
http://www.iotogo.com/s/072407B (Note: You may have to copy this link into your browser then press the [ENTER] key.)
Today's PriceWatch Alerts cover... More...>> |
| 07/05/2007 | 11:37AM | PRNUS | Seven Summits Research Releases Comments on VLO, AIG, MAR, GG, and BIIB
CHICAGO, July 5 /PRNewswire/ -- Seven Summits Research releases NewsBites on key stocks.
Seven Summits Strategic Investments NewsBites are available to all investors at:
http://www.go7now.com/nb/0705Z (Note: You may have to copy this link into your browser then press the [ENTER] key.)
Today's Seven Summits Strategic... More...>> |
| 05/15/2007 | 7:45AM | PRNUS | Jacobs Receives Contract From Biogen Idec for Biotechnology Project in Denmark
PASADENA, Calif., May 15 /PRNewswire-FirstCall/ -- Jacobs Engineering Group Inc. (NYSE:JEC) announced today that they received a contract from Biogen Idec (NASDAQ:BIIB) to provide engineering, procurement, validation, and site support services for the first cell culture manufacturing facility at the greenfield biotechnology... More...>> |
| 04/23/2007 | 11:06AM | PRNUS | Seven Summits Research Releases Comments on AAPL, SLB, DE, BTU, and BIIB
CHICAGO, April 23 /PRNewswire/ -- Seven Summits Research releases NewsBites on key stocks.
Seven Summits Strategic Investments NewsBites are available to all investors at:
http://www.go7now.com/nb/0423Z (Note: You may have to copy this link into your browser then press the [ENTER] key.)
Today's Seven Summits Strategic... More...>> |
| 04/09/2007 | 4:55PM | PRNUS | HealthShares(TM) Announces Change to the HealthShares(TM) Ophthalmology Index
NEW YORK, April 9 /PRNewswire/ -- HealthShares(TM) Inc., an investment company with a series of 20 underlying fund portfolios, today announced it has been informed by Standard & Poor's, the calculating agent for the HealthShares(TM) Ophthalmology Index, that effective at the opening of trading on Thursday April 12... More...>> |
| 03/12/2007 | 7:55AM | PRNUS | Primary Endpoint Met in Phase 2 Trial of Daclizumab in Patients With Relapsing Multiple Sclerosis
- Anti-IL-2 receptor antibody significantly reduced the number of new or enlarged lesions compared to placebo; data to be submitted for presentation at upcoming medical meeting -
CAMBRIDGE, Mass. and FREMONT, Calif., March 12 /PRNewswire-FirstCall/ -- Biogen Idec, Inc. (NASDAQ:BIIB) and PDL BioPharma, Inc. (PDL) (NASDAQ:PDLI... More...>> |
| 02/15/2007 | 9:31AM | PRNUS | Seven Summits Research Releases Alerts on QCOM, RIMM, OXY, BIIB, and AEOS
CHICAGO, Feb. 15 /PRNewswire/ -- Seven Summits Research issues PriceWatch Alerts for key stocks.
Seven Summits Strategic Investments' PriceWatch Alerts are available at http://www.iotogo.com/smu.asp?p=021507I (Note: You may have to copy this link into your browser then press the [ENTER] key.)
Today's PriceWatch Alerts... More...>> |
| 12/12/2006 | 9:31AM | PRNUS | Seven Summits Research Releases Alerts on CVX, DELL, BIIB, CBS, and IACI
CHICAGO, Dec. 12 /PRNewswire/ -- Seven Summits Research issues PriceWatch Alerts for key stocks.
Seven Summits Strategic Investments' PriceWatch Alerts are available at http://www.iotogo.com/smu.asp?p=121206A (Note: You may have to copy this link into your browser then press the [ENTER] key.)
Today's PriceWatch Alerts... More...>> |
| 11/11/2006 | 5:31PM | PRNUS | Subsequent Course of Rituxan(R) Improved Outcomes in Rheumatoid Arthritis Patients Who Inadequately Responded to TNF Antagonist
- Preliminary Safety Data on TNF Antagonist Use Following Rituxan Treatment Also Being Presented at the American College of Rheumatology Meeting -
SOUTH SAN FRANCISCO, Calif. and CAMBRIDGE, Mass., Nov. 11 /PRNewswire/ -- Genentech, Inc. (NYSE:DNA) and Biogen Idec, Inc. (NASDAQ:BIIB) today announced positive results... More...>> |
| 10/31/2006 | 9:31AM | PRNUS | Seven Summits Research Releases Alerts on VLO, X, ADM, CMI, and BIIB
CHICAGO, Oct. 31 /PRNewswire/ -- Seven Summits Research issues PriceWatch Alerts for key stocks.
Seven Summits Strategic Investments' PriceWatch Alerts are available at http://www.iotogo.com/smu.asp?p=103106A (Note: You may have to copy this link into your browser then press the [ENTER] key.)
Today's PriceWatch Alerts... More...>> |
| 10/16/2006 | 10:45AM | PRNUS | Seven Summits Research Releases Comments on SNDK, X, BP, LEN, and BIIB
CHICAGO, Oct. 16 /PRNewswire/ -- Seven Summits Research releases NewsBites on key stocks.
Seven Summits Strategic Investments NewsBites are available to all investors at http://www.go7now.com/nb.aspx?p=1016Z (Note: You may have to copy this link into your browser then press the [ENTER] key.)
Today's Seven Summits... More...>> |
| 09/29/2006 | 6:29PM | PRNUS | FDA Approves Two New Indications for Rituxan(R) in Patients With Non-Hodgkin's Lymphoma
- Rituxan Improves Progression-Free Survival When Used in Combination with CVP Chemotherapy as a First-Line Treatment in Patients with Follicular Non- Hodgkin's Lymphoma -
SOUTH SAN FRANCISCO, Calif. and CAMBRIDGE, Mass., Sept. 29
/PRNewswire-FirstCall/ -- Genentech, Inc. (NYSE:DNA) and Biogen Idec, Inc. (NASDAQ:BIIB... More...>> |
| 09/15/2006 | 10:53AM | PRNUS | Seven Summits Research Releases Comments on SBUX, YHOO, UTX, BIIB, and VRSN
CHICAGO, Sept. 15 /PRNewswire/ -- Seven Summits Research releases NewsBites on key stocks.
Seven Summits Strategic Investments NewsBites are available to all investors at http://www.go7now.com/nb.aspx?p=0915Z (Note: You may have to copy this link into your browser then press the [ENTER] key.)
Today's Seven Summits... More...>> |
|
|
|